DAVID V SMITH Insider Trading
Get free email notifications about insider trading for DAVID V SMITH.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID V SMITH. DAVID V SMITH is a V.P. & Chief Financial Officer in CHIRON CORP ($CHIR) and a V.P.; Chief Financial Officer in CHIRON CORP ($CHIR) and a Director in ONCOGENEX PHARMACEUTICALS, INC. ($OGXI) and an Executive Vice President & CFO in FIVE PRIME THERAPEUTICS INC ($FPRX) and a Director in CODEXIS INC ($CDXS).
Address: 4560 HORTON STREET EMERYVILLE 94608 CA
Companies in which DAVID V SMITH is an Insider
ACHIEVE LIFE SCIENCES, INC.
Trading Symbol: ACHVIndustry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of DAVID V SMITH: Director
Holdings: 9,500 shares
Current Value: $5,700
Latest Transaction: May 27 2016
$ACHV Market Capitalization: $18.31M
$ACHV Previous Close: $0.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CHIRON CORP
Trading Symbol: CHIRIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID V SMITH: V.P. & Chief Financial Officer, V.P.; Chief Financial Officer
Holdings: 0 shares
Latest Transaction: Apr 19 2006
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CODEXIS, INC.
Trading Symbol: CDXSIndustry: INDUSTRIAL ORGANIC CHEMICALS [2860]
Position of DAVID V SMITH: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 18 2020
$CDXS Market Capitalization: $179.31M
$CDXS Previous Close: $4.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
FIVE PRIME THERAPEUTICS, INC.
Trading Symbol: FPRXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID V SMITH: Executive Vice President & CFO
Holdings: 138,947 shares
Current Value: $6,305,415
Latest Transaction: Apr 19 2021
$FPRX Market Capitalization: $1.23B
$FPRX Previous Close: $45.38
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of DAVID V SMITH
Sentiment: All, ACHV, CHIR, CDXS, FPRX
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Option Exercise | D | 5.25 | 90,000 | 472,500 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Option Exercise | D | 5.25 | 90,000 | 472,500 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Option Exercise | D | 12.47 | 185,000 | 2,306,950 | 0 | |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Sell | D | 38.00 | 138,947 | 5,279,986 | 0 | 138.9 K to 0 (-100.00 %) |
Apr 19 2021 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Grant | A | 0.00 | 66,000 | 0 | 138,947 | 72.9 K to 138.9 K (+90.48 %) |
Feb 26 2021 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Payment of Exercise | F | 25.71 | 5,110 | 131,378 | 72,947 | 78.1 K to 72.9 K (-6.55 %) |
Dec 15 2020 | FPRX | FIVE PRIME THERAPE ... | Smith David V | Executive Vice Pres ... | Option Exercise | M | 0.00 | 22,000 | 0 | 0 |